Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20355)

 Full screen view
Filter results: >>>>
Cell Small Molecule GR50 GRmax GR_AOC GEC50 GRinf GR Hill Coefficient GR r2 pval_GR
SUM1315MO2 Alvocidib
0.111817025
 -0.7885 0.3864 0.2928 -1.0000 1.1414 0.9268
6.44e-15
CAL-51 Alvocidib
0.203450964
 -0.1017 0.2311 0.8363 -1.0000 0.7772 0.9758
1.11e-16
Hs 578T Alvocidib
0.148558558
 -0.2518 0.2560 0.2079 -0.3548 1.5955 0.9912
1.11e-16
MDA-MB-157 Alvocidib
0.152222738
 -0.8658 0.2879 0.2794 -1.0000 1.8087 0.9385
7.77e-16
MDA-MB-436 Alvocidib
0.162293194
 -0.0744 0.2528 0.1693 -0.0464 2.0866 0.9251
8.55e-15
SK-BR-3 Alvocidib
0.138970351
 -0.7648 0.3411 0.3016 -1.0000 1.4181 0.9513
1.11e-16
HME1 Alvocidib
0.114196744
 -0.3549 0.3125 0.4526 -1.0000 0.7978 0.9854
1.11e-16
MCF 10A Alvocidib
0.099467899
 -0.4802 0.3475 0.1398 -0.5288 2.1178 0.9920
1.11e-16
CAL-120 Alvocidib
-inf
 -0.0679
MDA-MB-468 Alvocidib
0.173077952
 -0.4235 0.2942 0.4622 -0.9850 1.1084 0.9659
1.11e-16
MCF7 Alvocidib
-inf
 -0.2526
AU565 Alvocidib
0.087632457
 -0.5502 0.3751 0.2006 -0.8064 1.1595 0.9601
1.11e-16
MDA-MB-361 Alvocidib
0.089713792
 -0.4956 0.4193 0.3494 -1.0000 0.8080 0.8065
1.21e-09
HCC1395 Alvocidib
0.123109246
 -0.6242 0.3359 0.3193 -1.0000 1.1526 0.9075
1.2e-13
HCC1143 Alvocidib
0.171201738
 -0.3370 0.2245 0.2832 -0.5220 1.4205 0.9893
1.11e-16
HCC1806 Alvocidib
0.165238718298
 -0.4850 0.2588 0.4377 -1.0000 1.1279 0.9859
1.11022302463e-16
BT-549 Alvocidib
0.161331919984
 -0.4334 0.2463 0.3134 -0.7128 1.3342 0.9894
1.11022302463e-16
HCC1419 Alvocidib
0.180879399
 -0.2626 0.2408 0.5478 -0.8902 0.9228 0.9420
3.33e-16
MDA-MB-453 Alvocidib
0.131746612
 -0.1949 0.2615 0.1512 -0.1882 2.3212 0.9251
8.55e-15